In a patient with cirrhosis of the liver, what complication could arise from using an amide local anesthetic?

• A. Complications metabolizing the drug
• B. Allergic reaction risk increases
• C. Increased renal clearance
• D. No adverse effects are expected

Answer: (A)

The key idea is that amide local anesthetics are primarily broken down by the liver. In cirrhosis, liver function is impaired and hepatic blood flow is often reduced, so metabolism of these drugs slows down. As a result, the drug stays in the bloodstream longer, leading to higher plasma levels and a greater risk of systemic toxicity. This can show up as central nervous system symptoms or cardiovascular depression if levels become high. Because of this, dosing must be more conservative in patients with cirrhosis, and alternatives or strategies to limit systemic absorption (like using vasoconstrictors and careful monitoring) may be considered.

The other options don’t fit as well. Allergic reactions aren’t inherently tied to liver disease and aren’t the primary concern here. Renal clearance isn’t the main issue with amides in cirrhosis, and assuming no adverse effects is incorrect given the potential for toxicity with impaired metabolism.